At first glance, this iPhone 6 case looks like a typical battery backpack. Turns out it's a bit more. Rick Broida is the author of numerous books and thousands of reviews, features and blog posts. He ...
ISTAND transitions to a permanent program, qualifying novel drug development tools (DDTs) to facilitate drug development. DDTs include AI algorithms, digital health technologies, and novel assays, ...
We have featured quite a few different cases and stands for the iPad here at Geeky Gadgets, and the latest one is certainly unique: the iStand. As you can see from the photo, the iStand is designed to ...
It's a stand for the iPad, and so of course it is called the iStand, but it's also an elegant piece of furniture. The Danish-designed stand is aimed at POS use (no, not that POS) and holds the iPad at ...
An Indiegogo crowdsourcing campaign for iStand 6, an MFi-certified combined power case and stand for the iPhone 6, starts today – with early bird pricing starting at just $40. The iStand 6 is the ...
An Indiegogo crowdsourcing campaign for iStand 6, an MFi-certified combined power case and stand for the iPhone 6, starts today – with early bird pricing starting at just $40. The iStand 6 is the ...
ATLANTA--(BUSINESS WIRE)--Axion BioSystems today announced that the FDA's Center for Drug Evaluation and Research (CDER) has accepted the company’s letter of intent (LOI) into the Innovative Science ...
SmartWalk products, like the cane, are designed with senior falls and Alzheimer's in mind. SmartWalk requires no subscription for Fall Detection Alerts, GPS location, and Alzheimer'sAlert's™. Not just ...
In our second episode of the miniseries by the WWEST Associate Chair program hosted at iSTAND at the University of British Columbia Okanagan (UBCO), host Maxine (iSTAND Communications and Resource ...
In our third episode of the miniseries by the WWEST Associate Chair program hosted at iSTAND at the University of British Columbia Okanagan (UBCO), host Maxine (iSTAND Communications and Resource ...
Axion BioSystems’ Letter of Intent for its Human iPSC-Cardiomyocyte MEA Assay for Prediction of Clinical Cardiovascular Repolarization Risk has been accepted into the FDA's ISTAND Program. The ISTAND ...